|
Market Cap (17-May) $8,414,961,152 (204th) |
Close (30-Jun) $11.22 |
Volume (30-Jun) 664,557 |
Shortsold (5-May) 16,072,273 (4.76%) (53rd) |
|
52w High $31.97 |
52w Low $14.42 |
P/E 57.80 |
EPS 0.15 |
TLX released this announcement to the ASX on 16 December 2020, 8:21. The announcement is not marked as price sensitive, and is 2 page(s) in length and 203.05kb in size.
You can view all announcements from TLX and see how they appear on a price chart on the announcements page.
At the date of this announcement, TLX was 0.033% short sold according to ASIC data. It was ranked the 495th most shorted stock on the ASX. It is now ranked as the 53rd most shorted stock on the ASX with 4.757% of total shares short sold as of the latest reported data (05 May 2025).
| Other Recent Announcements from TLX | |
|---|---|
| Cleansing Notice | 28 June 2023, 8:23 |
| Application for quotation of securities - TLX | 28 June 2023, 8:23 |
| Proposed issue of securities - TLX | 21 June 2023, 18:12 |
| Urologic Oncology Alliance with Mauna Kea Technologies | 16 December 2020, 8:21 |
| IP Agreement with U Southampton for access to TRALA data | 14 December 2020, 8:33 |
| Cleansing Notice under section 708A Corporations Act | 14 December 2020, 8:24 |
| Appendix 2A - issue of shares from exercise of options | 14 December 2020, 8:24 |
You must be logged in to post a reply.
Telix Pharmaceuticals 